Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

Cancer treatment by immune checkpoint blockade (ICB) can bring long-lasting clinical benefits, but only a fraction of patients respond to treatment. To predict ICB response, we developed TIDE, a computational method to model two primary mechanisms of tumor immune evasion: the induction of T cell dys...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Med
Principais autores: Jiang, Peng, Gu, Shengqing, Pan, Deng, Fu, Jingxin, Sahu, Avinash, Hu, Xihao, Li, Ziyi, Traugh, Nicole, Bu, Xia, Li, Bo, Liu, Jun, Freeman, Gordon J., Brown, Myles A., Wucherpfennig, Kai W., Liu, X. Shirley
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6487502/
https://ncbi.nlm.nih.gov/pubmed/30127393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41591-018-0136-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados